These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 9147616
1. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha. Seong J, Milross CG, Hunter NR, Shin HC, Milas L. Anticancer Drugs; 1997 Jan; 8(1):80-7. PubMed ID: 9147616 [Abstract] [Full Text] [Related]
2. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. Milross CG, Mason KA, Hunter NR, Chung WK, Peters LJ, Milas L. J Natl Cancer Inst; 1996 Sep 18; 88(18):1308-14. PubMed ID: 8797771 [Abstract] [Full Text] [Related]
8. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK. Cancer Res; 1999 Aug 01; 59(15):3776-82. PubMed ID: 10446995 [Abstract] [Full Text] [Related]
9. Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel. Inoue T, Li C, Yang DJ, Higuchi T, Oriuchi N, Yu D, Milas L, Hunter N, Wallace S, Kim EE, Podoloff DA. Ann Nucl Med; 1999 Jun 01; 13(3):169-74. PubMed ID: 10435377 [Abstract] [Full Text] [Related]
10. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M, Ettenberg SA, Nau MM, Lipkowitz S. Gynecol Oncol; 2001 Jun 01; 81(3):380-90. PubMed ID: 11371126 [Abstract] [Full Text] [Related]
11. Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma. Milas L, Saito Y, Hunter N, Milross CG, Mason KA. Radiother Oncol; 1996 Aug 01; 40(2):163-70. PubMed ID: 8884971 [Abstract] [Full Text] [Related]
12. [Inhibition of tumor neo-angiogenesis and induction of apoptosis as properties of docetaxel (taxotere)]. Schimming R, Hunter NR, Mason KA, Milas L. Mund Kiefer Gesichtschir; 1999 Jul 01; 3(4):210-2. PubMed ID: 10474267 [Abstract] [Full Text] [Related]
13. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Saito Y, Milross CG, Hittelman WN, Li D, Jibu T, Peters LJ, Milas L. Int J Radiat Oncol Biol Phys; 1997 Jun 01; 38(3):623-31. PubMed ID: 9231689 [Abstract] [Full Text] [Related]
14. Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate. Li C, Ke S, Wu QP, Tansey W, Hunter N, Buchmiller LM, Milas L, Charnsangavej C, Wallace S. Int J Radiat Oncol Biol Phys; 2000 Nov 01; 48(4):1119-26. PubMed ID: 11072171 [Abstract] [Full Text] [Related]
16. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor. Manetta A, Emma D, Gamboa G, Liao S, Berman M, DiSaia P. Gynecol Oncol; 1993 Jul 01; 50(1):38-44. PubMed ID: 8349163 [Abstract] [Full Text] [Related]
18. Docetaxel enhances tumor radioresponse in vivo. Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2431-8. PubMed ID: 9815644 [Abstract] [Full Text] [Related]
19. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. Nielsen LL, Lipari P, Dell J, Gurnani M, Hajian G. Clin Cancer Res; 1998 Apr 01; 4(4):835-46. PubMed ID: 9563876 [Abstract] [Full Text] [Related]
20. Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo. Milross CG, Mason KA, Hunter NR, Terry NH, Patel N, Harada S, Jibu T, Seong J, Milas L. Eur J Cancer; 1997 Jul 01; 33(8):1299-308. PubMed ID: 9301459 [Abstract] [Full Text] [Related] Page: [Next] [New Search]